Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other 1

Conditions

Neoplasms 14Lung Neoplasms 10Breast Neoplasms 9Colorectal Neoplasms 8Prostatic Neoplasms 7Stomach Neoplasms 3Rectal Neoplasms 3Polycystic Ovary Syndrome 3Neoplasm Metastasis 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Smoking Cessation 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic cancer, adult 2Ovarian Neoplasms 2Neoplastic Cells, Circulating 2Motor Activity 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Endometrial Neoplasms 2Wilms Tumor 1Venous Thromboembolism 1Vaginal Neoplasms 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1Testicular Germ Cell Tumor 1Stroke 1

Interventions

Surveys and Questionnaires 5Oxygen 2Dexamethasone 2Calcium Dobesilate 2Acupuncture Therapy 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Tiotropium Bromide 1Sugars 1Standard of Care 1Respiratory Therapy 1Rehabilitation 1Psychiatric Rehabilitation 1Midazolam 1Losartan 1Lisinopril 1Hypnosis 1Hematologic Tests 1Furosemide 1Fentanyl 1Exercise 1Educational Status 1Echocardiography 1Early Intervention, Educational 1Dexmedetomidine 1Caregivers 1Buspirone 1Behavior Therapy 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dyspnea × Hematologic Tests × Clear all
NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

Terminated
50 enrolled
OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡